DNA inter-strand crosslink (ICL) repair requires a complicated network of DNA damage response pathways. Removal of these lesions is vital as they are physical barriers to essential DNA processes that require the separation of duplex DNA, such as replication and transcription. The Fanconi anemia (FA) pathway is the principle mechanism for ICL repair in metazoans and is coupled to replication. In Saccharomyces cerevisiae, a degenerate FA pathway is present, but ICLs are predominantly repaired by a pathway involving the Pso2 nuclease that is hypothesized to digest through the lesion to provide access for translesion polymerases. However, Pso2 lacks translesion nuclease activity in vitro, and mechanistic details of this pathway are lacking, especially relative to FA. We recently identified the Hrq1 helicase, a homolog of the disease-linked RECQL4, as a novel component of Pso2-mediated ICL repair. Here, we show that Hrq1 stimulates the Pso2 nuclease in a mechanism that requires Hrq1 catalytic activity. Importantly, Hrq1 also stimulates Pso2 translesion nuclease activity through a site-specific ICL in vitro. Stimulation of Pso2 nuclease activity is specific to eukaryotic RecQ4 subfamily helicases, and Hrq1 likely interacts with Pso2 through their N-terminal domains. These results advance our understanding of FAindependent ICL repair and establish a role for the RecQ4 helicases in the repair of these dangerous lesions.
Introduction
DNA inter-strand crosslinks (ICLs) are covalent linkages between complementary DNA strands, and they act as physical barriers to essential DNA transactions like replication and transcription (1) . Repair of these lesions is vital for cell survival, and 20-40 lesions are lethal to repair-deficient mammalian cells (2) . For this reason, DNA damaging agents that cause ICLs are common chemotherapeutics, and upregulation of pathways that repair these lesions is a known source of chemotherapeutic resistance (1) . To date, the most thoroughly studied ICL repair mechanism involves the Fanconi anemia (FA) pathway in which over 20 proteins are involved (3) . The main mechanism for FA-dependent ICL repair is coupled to DNA replication. Briefly, the replisome stalls 20-40 nts from the ICL, which results in uncoupling of the MCM2-7 replicative helicase and DNA synthesis to within 1 nt of the lesion (4) . Unhooking of the lesion is accomplished by a suite of nucleases that act in a context-specific manner (reviewed in (5) ). This results in a DNA double-strand break (DSB), which is repaired by homologous recombination (HR). Subsequently, translesion polymerases replicate past the remaining ICL adduct, and nucleotide excision repair (NER) factors remove the remaining adducted nucleotide.
However, it has also been shown that a large number of ICLs can be bypassed by an intact replisome in a traverse model in a FAdependent manner (6) . Variations of this mechanism are dependent on the context in which the ICL is identified, and the FA pathway only accounts for ICL repair during S-phase. Importantly, there are numerous ICL repair factors that do not fall within the FA complementation group, including proteins in the SAN1/SETX pathway (7) , base excision repair-associated ICL repair (8, 9) , the repair of acetaldehyde-derived ICLs (10) , and the SNM1/Pso2 family nucleases (11). Taken together, ICL repair requires the complex coordination of multiple pathways that depend on the context of the lesion.
Of the three SNM1 proteins in humans (SNM1A, SNM1B (Apollo), and SNM1C (Artemis)), SNM1A is the most directly linked to ICL repair (11), though SNM1B has a role in ICL repair that is independent of SNM1A (12) . The model for SNM1A in ICL repair starts with FAN1 and NER factors such as XPF-ERCC1 using their endonuclease activity to create a single-stranded (ss)DNA nick on either the 5′ side of the lesion or on both sides, though other nucleases have been implicated in this process (reviewed in (5) ). SNM1A uses its 5′ → 3′ exonuclease activity to digest from the incision through the ICL, facilitating gap fill-in by translesion synthesis (TLS) DNA polymerases (13) . While SNM1A appears to play an important role in ICL repair in vertebrates, the FA pathway is the dominant mechanism for ICL repair. However, the Saccharomyces cerevisiae homolog of SNM1A, Pso2, is involved in the predominant pathway for ICL repair in yeast (14, 15) . Indeed, human SNM1A is able to suppress the sensitivity of pso2Δ cells to ICL damage (16) . Similar to its human counterpart, Pso2 possesses 5′ → 3′ exonuclease activity (17) , and is reported to have structure-specific endonuclease activity when used at high concentrations in vitro (18) . However, Pso2 lacks the ability to digest through an ICL in vitro, making the mechanism ICL repair via the Pso2 pathway unclear. We recently identified the S. cerevisiae RECQL4 homolog, the Hrq1 helicase, as an additional component of the Pso2-dependent ICL repair pathway (14) and are seeking to further define its role.
The RecQ family helicases are conserved mediators of genome stability, with five family members encoded by the human genome (reviewed in (19) ). Mutations in three of the human RecQ helicases (BLM, WRN, and RECQL4) are directly linked to diseases that clinically overlap in their predisposition to cancer and premature aging phenotypes. The involvement of RECQL4 in ICL repair is unclear (20) , largely due to technical challenges associated with RECQL4 analysis. Since the identification of RecQ4 helicases in various fungal and plants species (21) , new homologs have been identified in bacteria and archaea (22, 23) , making RECQL4 the only RecQ subfamily helicase conserved in all three domains of life. Recent work on the RECQL4 homologs in Arabidopsis thaliana (24) and S. cerevisiae (14, 25) , both called Hrq1, demonstrates that they are involved in ICL repair, similar to RECQL4 (26) . Furthermore, Hrq1 appears to be a bona fide RECQL4 homolog in vitro and in vivo, making it a good model for RECQL4-mediated DNA repair (14, 25, 27) . Hrq1 is currently the only known protein to work with Pso2 at the post-incision step of ICL repair, but its mechanism of action is unclear.
Here, we provide further evidence that Hrq1 functions alongside Pso2 to repair ICL lesions that vary in their DNA sequence preference and effect on DNA structure. In vitro, Hrq1 stimulated Pso2 nuclease activity in a reaction that requires Hrq1 catalytic activity, and this phenomenon was specific to RecQ4 subfamily helicases. Importantly, we also found that Pso2 stalling at a site-specific ICL can be overcome in the presence of Hrq1. Finally, we demonstrate that the Pso2 N-terminus is an autoinhibitory domain that may act as the interaction platform for Hrq1-mediated nuclease stimulation. These data support the direct role of RecQ4 family helicases in ICL processing and provide mechanistic insight into the Pso2-dependent ICL repair pathway.
Results

Hrq1 and Pso2 repair a variety of ICLs
All ICLs are covalent linkages between complementary strands of DNA, but ICLinducing agents vary in DNA sequence preference and how they affect DNA structure (reviewed in (28) ). Indeed, ICL repair pathway utilization in mammals varies depending on the types of crosslinkers being used. For example, highly DNA-distorting lesions like cisplatin and nitrogen mustard ICLs are repaired via the canonical FA pathway (4), whereas psoralen-and abasic site-induced ICLs are preferentially unhooked via the NEIL3 DNA glycosylase in a FA-independent manner (29) . To determine if the Pso2dependent ICL repair pathway in S. cerevisiae is dependent on the type of ICL formed, we tested the sensitivity of pso2 mutants to several ICL-inducing agents. First, we examined the sensitivity of pso2Δ cells to mitomycin C (MMC), diepoxybutane (DEB), and 8-methoxypsoralen (8-MOP) + UVA. As diagrammed in Figure S1A , MMC does not distort the DNA backbone, DEB bends the DNA, and 8-MOP + UVA leads to ~25° unwinding of the DNA around the lesion. Further, all three ICL inducing agents target different DNA sequences. Regardless of the type of ICL formed, deletion of PSO2 severely sensitized cells to each type of ICL ( Fig. 1 and S1). Similar to cells lacking PSO2 and previously reported results (14, 25) , mutation of HRQ1 also rendered cells sensitive to the various ICL-inducing agents ( Fig. 1 and S1), though Hrq1 does not appear to be as important in ICL repair as Pso2 because hrq1Δ cells were less sensitive to ICL damage than pso2Δ cells. Importantly, the deletion of both HRQ1 and PSO2 phenocopied the pso2Δ levels of MMC ( Fig. 1A ) and DEB sensitivity ( Fig. 1B) , consistent with Hrq1 functioning in the Pso2-dependent pathway. The observed sensitivity of these mutants is specific to ICL damage as neither pso2Δ nor hrq1Δ cells were sensitive to the DNA alkylating agent methyl methanesulfonate (MMS) (30) (Fig. S1A ).
Hrq1 helicase activity is required for the repair of MMC ICLs (25) , so we also tested the sensitivity of cells encoding hrq1-K318A, a helicase-inactive mutant of Hrq1, to DEB and 8-MOP + UVA. We found that the hrq1-K318A mutant is more sensitive to ICLs compared to the hrq1Δ strain ( Fig. 1 and S1). These results suggest that Hrq1-K318A is recruited to the lesion but is perhaps blocking Pso2 or other redundant repair pathways from accessing the site of damage. Because the hrq1-K318A strain is slightly less sensitive than pso2Δ, however, some amount of Pso2 or a compensatory pathway likely still has access to repair the lesion. This contrasts with the pso2-H611A nuclease-inactive mutant, which phenocopies pso2Δ. These results suggest that Hrq1 may be directly recruited to DNA ICLs and that it may work with Pso2 to repair these lesions.
Hrq1 stimulates Pso2 nuclease activity
Our genetic analyses suggest that Hrq1 may have a direct role in ICL processing alongside Pso2. Indeed, there is a rich literature of RecQ family helicases and nucleases working in tandem (for instance, see: (31, 32) ). To investigate this further, we purified recombinant Pso2 and tested it for nuclease activity on blunt dsDNA. Similar to previous work with Pso2 (18) , we observed 5′ phosphate-dependent 5′ → 3′ exonuclease activity ( Fig. 2A) . Here, only the radiolabelled oligonucleotide was 5′-phosphorylated to select for digestion of one strand (Fig. S2A ).
In the presence of Hrq1, Pso2 nuclease activity increased in a concentration dependent manner up to a nearly threefold stimulation ( Fig. 2B) . At 200 nM, Pso2 digested ~80% of the fulllength substrate, while 50 nM Pso2 was able to digest nearly as much DNA upon the addition of 150 nM Hrq1.
To verify that our observed nuclease activity was due to Pso2 and not a contaminant from E. coli, we purified the nuclease-null Pso2-H611A mutant and tested its nuclease activity. Importantly, Pso2-H611A showed no nuclease activity above background, and no stimulation of the mutant was observed in the presence of Hrq1 ( Fig. 2C and S2B ). Because Hrq1 helicase activity was required for ICL repair in vivo ( Fig. 1 and S1), we also assayed the catalytically inactive Hrq1-K318A for stimulation of Pso2 nuclease activity in vitro. Hrq1-K318A was unable to increase Pso2 nuclease activity, suggesting that Hrq1 catalytic activity is essential to stimulate Pso2 (Fig. S2B ). Taken together, the data indicate that Hrq1 stimulates the exonuclease activity of Pso2.
Hrq1 promotes Pso2 digestion through an ICL
It has been reported that Pso2 lacks translesional nuclease activity in vitro, being unable to degrade DNA past a site-specific ICL (18) . However, the human homolog of Pso2, SNM1A, does display in vitro translesion exonuclease activity (13) . Because Hrq1 can stimulate Pso2 nuclease activity on undamaged DNA, we hypothesized that Hrq1 may also stimulate its translesional nuclease activity across an ICL. Thus, we next performed nuclease assays with a dsDNA substrate containing an ICL 7-nt from the 5′ end of the phosphorylated (i.e., the digested) strand. To make this substrate, we used an established protocol to form ICLs from abasic sites in vitro (33) . These ICLs are site specific and produced at high yields (up to ~70% crosslinks), which is advantageous relative to the difficult-to-make drug-based ICLs (28) . Semlow et al. show that the repair of ICLs from abasic sites proceeds via the same mechanism that repairs psoralen ICLs (29) , suggesting that this type of lesion is functionally equivalent to ICLs induced by small molecules.
Due to difficulties in reversing the crosslink in our substrate for denaturing PAGE analysis, gel-based assays of Pso2 translesion nuclease activity were inconclusive (data not shown). To investigate this in a more definitive manner, we instead utilized single-molecule Förster resonance energy transfer (smFRET) to measure Pso2 nuclease activity. To observe nuclease activity, we prepared a DNA substrate that contains Cy3, Cy5, and biotin in the undigested strand, which was annealed to an unlabelled but 5ʹ-phosphorylated strand to be digested by Pso2 (Fig. 3A ). Because the FRET efficiency reports on the distance between the donor and acceptor, the FRET signals of dsDNA and ssDNA can be distinguished as low and high FRET, respectively (34) . Therefore, the changes in FRET signal as ssDNA is generated by Pso2 digestion of the unlabelled strand can be used to measure nuclease activity. Thus, we expected to see no change in FRET in the initial phase of Pso2 loading, followed by FRET increase induced by Pso2 digestion and concomitant generation of ssDNA and subsequent high FRET state resulting from the completion of the digestion (Fig. 3A) .
To calibrate the smFRET system, we measured FRET from the dsDNA substrate and unannealed ssDNA as undigested and completely digested controls, respectively. The FRET histograms of dsDNA and ssDNA produced sharp peaks at the expected values of 0.32 and 0.80, respectively ( Fig. 3B ). Next, we applied varying conditions of Pso2 and Hrq1 and collected images in 10-min intervals to measure the FRET change over time. Upon adding 50 nM Pso2 alone, < 10% of molecules shifted to high FRET after 30 min ( Fig. 3C ) in a Mg 2+ -dependent manner ( Fig. S3A ). However, longer time courses (> 40 min) of Pso2 nuclease activity revealed that Pso2 was able digest nearly 50% of the substrate (Fig.  S4A ). When Hrq1 was added without Pso2, the FRET peak remained unchanged in the absence and presence of ATP ( Fig. S3A) , consistent with the fact that Hrq1 does not bind and unwind blunt dsDNA (14) . In contrast, when 50 nM Pso2 and 150 nM Hrq1 were incubated together in our FRET assay, we observed a dramatic increase in high FRET signal within minutes ( Fig.  3C ). Approximately 76% of molecules were digested in 10 min, with nearly 100% of the DNA digested by 30 min. This stimulation was dependent upon ATP and the catalytic activity of Hrq1, as it was absent when Hrq1-K318A was added to the reaction (data not shown). These smFRET results are highly correlated to our gel-based assays, which also display significantly enhanced Pso2 nuclease activity by Hrq1 ( Fig. 2 ).
Next, we compared the nuclease-helicase coupled activity on undamaged DNA vs. a substrate containing a site-specific ICL (XL-DNA). In the absence of Hrq1, Pso2 digested 6% of the undamaged DNA in 10 min, but no activity was detected for Pso2 digestion of XL-DNA ( Fig. 4 and S3B), indicating that Pso2 has little to no translesion nuclease activity alone. Even with longer incubation times and in contrast to undamaged DNA, Pso2 was unable to digest a measurable amount of XL-DNA ( Fig. S4B ). Strikingly, in the presence of Hrq1, 62% of the XL-DNA substrate was digested by Pso2 ( Fig. 4A and B).
We then asked if the enhanced Pso2 activity requires ATP hydrolysis by Hrq1. To address this question, we conducted the FRET-based nuclease assay in the absence of ATP. Without ATP, Pso2 + Hrq1 digested only 17% of undamaged DNA and no XL-DNA after 10 min ( Fig. 4) . These values are more comparable to Pso2 in the absence of Hrq1. Similarly, we measured Pso2 nuclease activity in the presence of the ATPase-null Hrq1-K318A mutant, which yielded 8.5% digestion product for undamaged DNA and none for XL-DNA (data not shown), confirming that the ATPase activity of Hrq1 is essential for promoting Pso2 nuclease activity. Taken together, our ensemble biochemical analyses and single molecule data demonstrate that Hrq1 significantly stimulates Pso2 nuclease activity on both undamaged DNA and XL-DNA, and the enhancement requires the catalytic activity of Hrq1.
Eukaryotic RecQ4 sub-family helicases specifically stimulate Pso2
As stated above, it is not uncommon for helicases and nucleases to function together in DNA repair pathways, as observed with the extensive resection by Sgs1 and Dna2 in HR (35) . To determine if the stimulation of Pso2 nuclease activity is a result of general helicase activity or specifically related to Hrq1, we tested RecQ4 sub-family helicases from different species for their ability to stimulate Pso2 nuclease activity. We also tested Sgs1, the other RecQ family helicase in S. cerevisiae (homologous to BLM (36)), for its ability to stimulate Pso2 nuclease activity. Interestingly, both Hrq1 and human RECQL4 were able to significantly stimulate Pso2 ( Fig. 5A and B) . In contrast, the Hrq1 homolog from Mycobacterium smegmatis, called SftH (22) , was unable to stimulate Pso2, suggesting this phenomenon is specific to eukaryotic RecQ4 helicases. It should be noted that the M. smegmatis genome does not encode a homolog of Pso2, so if SftH is involved in ICL repair, it likely functions via a different mechanism than Hrq1/RECQL4.
Sgs1 yielded a level of Pso2 stimulation that was intermediate between SftH and
Hrq1/RECQL4 ( Fig. 5A and B), though it was not significant (p = 0.2). This suggests that the observed synergy with Pso2 is specific to eukaryotic RecQ4 sub-family helicases. However, while sgs1Δ cells are also sensitive to ICL damage, they are not epistatic to hrq1Δ (25) , suggesting that Sgs1 does not function in the Pso2 ICL repair pathway. To investigate this, we performed epistasis analysis with all three of the hrq1Δ, pso2Δ, and sgs1Δ alleles. As shown in Figures 1 and S1B, we recapitulated the synergistic ICL sensitivity of the hrq1Δ sgs1Δ double mutant relative to either of the single mutants (25) and found that the same was true of the pso2Δsgs1Δ double and hrq1Δ pso2 Δsgs1Δ triple mutants. Thus, in vivo, Sgs1 does not participate in the Pso2 ICL repair pathway, even in the absence of Hrq1.
While the results in Figure 5A and B suggest a direct interaction between Pso2 and eukaryotic RecQ4 sub-family helicases, it is also possible that Hrq1 and RECQL4 stimulate Pso2 nuclease activity indirectly by unwinding the DNA probe to provide a more accessible ssDNA substrate for Pso2. While all tested helicases were able to unwind a Y-shaped fork substrate ( Fig. 5C ), the blunt dsDNA substrate used in the nuclease assays was not unwound by Hrq1, RECQL4, or SftH in vitro, while Sgs1 was able to unwind blunt dsDNA. The inability of Hrq1 and RECQL4 to unwind a blunt DNA substrate is consistent with our previous work (14) , while the ability of Sgs1 to unwind a similar substrate has been previously reported (37) . Thus, the modest amount of Pso2 stimulation by Sgs1 shown in Figure 5A and B could be due to the helicase simply generating ssDNA for Pso2 to degrade, but Hrq1 and RECQL4 must function by a different mechanism. Taken together, these results suggest that Hrq1/RECQL4 and Pso2 directly interact to promote the digestion of ICL-containing lesions.
Hrq1 and Pso2 likely interact through their N-terminal domains (NTDs)
To determine if Hrq1 and Pso2 directly interact, we performed protein-protein crosslinking using the primary amine-targeting disuccinimidyl sulfoxide (DSSO). Incubation of 500 nM Hrq1 (the ~130 kDa band) with equimolar amounts of Pso2 in the presence of excess DSSO resulted in a high molecular weight species of approximately 180 kDa in mass as revealed by a western blotting ( Fig.  6A ). This product could correspond to an Hrq1-Pso2 crosslinked complex. Interestingly, the presence of this 180 kDa product was not dependent on the presence of DNA, but a molar excess of Hrq1 relative to Pso2 increased the amount of this species. This is consistent with our biochemical analyses that suggest a higher Hrq1:Pso2 ratio is optimal for nuclease stimulation (Fig. 2B ). However, this association also appeared to be weak, as we were unable to demonstrate it via coimmunoprecipitation of Hrq1 and Pso2 from S. cerevisiae lysates, in which both proteins (especially Pso2) exist at very low levels (data not shown). Unfortunately, we also could not artificially elevate the intracellular levels of Pso2 because over-expression led to toxicity ( Fig. S5 ).
We previously hypothesized that the disordered N-terminus of Hrq1 could be an important docking site for protein-protein interactions (14) . Similarly, Pso2 is also predicted to possess an unstructured NTD ( Fig.  6A ). To determine the role of the Pso2 Nterminus in Hrq1-mediated nuclease stimulation, we first compared the nuclease activity of full-length Pso2 to an N-terminal truncation of the first 94 residues (referred to as Pso2ΔN). Interestingly, we found that Pso2ΔN had significantly more nuclease activity than full-length Pso2 (Fig. 6B ), suggesting that the Pso2 N-terminus is an autoinhibitory domain. This phenomenon is conserved in the human homolog of Pso2, SNM1A, whose N-terminal truncation is also more active in vitro (13) . A nuclease-null mutant of Pso2ΔN (Pso2ΔN-H611A) purified identically to Pso2ΔN lacked detectable nuclease activity in vitro, indicating that this effect was not due to the presence of a contaminating E. coli nuclease (data not shown).
The addition of Hrq1 did not result in stimulation of Pso2ΔN (Fig. 6B ), though the highly efficient nuclease activity of the truncation may have already been maximal when used at 20 nM, which is a concentration at which stimulation of full-length Pso2 by Hrq1 can be observed. To test this, we measured the nuclease activity of 2 nM Pso2ΔN, which has a more comparable amount of nuclease activity to 20 nM fulllength Pso2 (Fig. S6B ). Hrq1 very mildly stimulated Pso2ΔN nuclease activity under these conditions, but not nearly to the levels of full-length Pso2. These data suggest that the Pso2 N-terminus is an autoinhibitory domain that also interacts with Hrq1 to mediate the observed nuclease activity stimulation.
Because M. smegmatis SftH was unable to stimulate Pso2 ( Fig. 5A and B ), we hypothesized that its lack of a large, natively disordered NTD like Hrq1 and RECQL4 may be the reason for this difference. Thus, we measured stimulation of Pso2 by an Hrq1 Nterminal truncation of residues 1-279 (known as Hrq1ΔN). Hrq1ΔN was unable to stimulate Pso2 nuclease activity ( Fig. 6B ), suggesting the interaction interfaces for both proteins are their disordered N-termini. The in vivo activity of these mutants also supports this conclusion as the ICL sensitivity of cells expressing Hrq1ΔN rather than the full-length helicase phenocopied that of a strain completely lacking Hrq1, and pso2Δ and pso2ΔN cells were also similarly sensitive to ICL damage ( Fig. 6C ).
Discussion
The above analyses of the genetic and biochemical interaction between Hrq1 and Pso2 suggest that the mechanistic role of Hrq1 in the Pso2 ICL repair pathway is to stimulate the translesional nuclease activity of Pso2, facilitating efficient repair of ICLs from multiple sources. Our ensemble and singlemolecule biochemistry results indicate that Pso2 alone is unable to digest DNA past a sitespecific ICL, but Hrq1 greatly stimulates this activity in an ATP-dependent manner. This phenomenon is specific to the eukaryotic RecQ4 helicases, likely due to an NTD-to-NTD physical interaction between the helicase and nuclease. Importantly, these results explain why recql4 mutant cell lines are sensitive to ICLs, and this DNA damage repair deficiency may underlie the genomic instability characteristic of RECQL4-linked diseases.
Implications for FA-independent ICL repair across evolution
It is clear that the FA pathway is the key ICL repair pathway in metazoans during S-phase (4), but it has more recently been appreciated that FA-independent ICL repair occurs in other in vivo contexts, such as during other phases of the cell cycle and when RNA polymerase encounters an ICL (7, 38) . In non-metazoan organisms, the FA pathway is also not the dominant ICL repair pathway or absent altogether. For instance, S. cerevisiae predominantly uses the Pso2 repair pathway but contains a rudimentary FA pathway containing obvious homologs of some of the metazoan enzymes involved in ICL repair (12, 15) . However, FA homologs appear to be lacking in prokaryotes, and thus, additional solutions to ICL repair must exist.
The data presented here and in our previous work (27) indicate that the Hrq1 helicase is involved in FA-independent ICL repair. This mirrors what is known about human RECQL4 in ICL repair in that recql4 mutant cells are sensitive to the ICL-inducing drug cisplatin (26) , and RECQL4 does not belong to any of the known FA complementation groups (39, 40) . Work on the Hrq1 homologs in Schizosaccharomyces pombe (41) and A. thaliana (24) also supports a role for these helicases in ICL repair, and the more distantly related Hrq1 homolog in Bacillus subtilis named MrfA was recently reported to have a role in the repair of MMC-induced lesions (23) .
Thus, the bacterial RecQ4 family helicases likely function in ICL repair and/or the repair of similar types of DNA damage. Although the function of archaeal RecQ4 helicases (also called SftH (22)) is, to our knowledge, completely unexplored, it is tempting to speculate that they are also involved in ICL repair based on homology to their bacterial and eukaryotic homologs.
Regardless, the involvement of RecQ4 family helicases in ICL repair across 3 billion years of evolution may indicate that the repair pathway in which these helicases function is one of the original mechanisms that developed to combat ICL damage, with the FA pathway evolving much later. ICL repair is a critical genome stability pathway, not just in the face of bifunctional exogenous compounds that cause ICLs but also due to endogenous sources of ICL damage. For instance, acetaldehyde is a metabolite produced during ethanolic fermentation that can cause DNA ICLs. It accumulates intracellularly (42) , especially when exogenous ethanol concentrations are low (43) , and thus ICLs are more apt to occur during the early stage of fermentation. Although we did not test hrq1Δ or pso2Δ cells for sensitivity to endogenous sources of ICLs, sensitivity of hrq1 mutants to acetaldehydederived ICLs would explain why HRQ1/hrq1Δ diploids display haploinsufficiency specifically during the early phase of wine fermentation but not later stages when the exogenous ethanol concentration is high (44) .
In light of the evolutionary importance of Hrq1-type helicases and ICL repair, it should be noted that not all prokaryotes encode a RecQ4 helicase, with E. coli being a prime example. In such organisms, ICL repair is performed by the concerted activities of the UvrABC endonuclease and recombination machinery (45, 46) . Similarly, not all organisms expressing a RecQ4 sub-family helicase encode a homolog of Pso2/SNM1A (e.g., B. subtilis and M. smegmatis), so other nucleases that function with RecQ4 helicases in ICL repair in such species remain to be identified. It is also likely that other factors in these pathways await discovery. In the case of S. cerevisiae Hrq1 and Pso2, what recruits these enzymes to the site of the ICL, are they the only proteins responsible for degradation of one strand of the crosslinked DNA and unhooking of the ICL, and what dictates the choice of ICL repair pathway (Hrq1/Pso2 vs. the FA-like pathway)? It is our hope that continued work in the yeast model will answer these questions and begin to shed light on the roles of RECQL4, SNM1A, and other factors in human ICL repair.
How does Hrq1 stimulate Pso2?
Our genetic and biochemical analyses of the Pso2 NTD suggest that it is important for ICL repair and likely acts as the protein-protein interaction interface for Hrq1. Thus, it is possible that Hrq1 and Pso2 form a complex in which Hrq1 translocates 3′ → 5′ along the undigested strand, while Pso2 degrades the complementary strand in the 5′ → 3′ direction in a mechanism similar to the Sgs1-Dna2 helicase-nuclease complex used in DSB repair (32) . Alternatively, Hrq1 and Pso2 may interact more dynamically and specifically when Pso2 stalls. We found that Pso2 alone had very low nuclease activity and processivity ( Fig. 2A) , which is sufficient for digestion of the short (20-40 nt) excision substrate produced by NER factors in ICL repair. When Pso2 stalls randomly on undamaged DNA or specifically at an ICL, Hrq1 may eject the unproductive nuclease to allow rebinding of Pso2 to continue DNA degradation. A similar model has been proposed for the Hrq1 stimulation of telomerase (47) .
The requirement of Hrq1 catalytic activity to stimulate Pso2 suggests that Hrq1 does not promote nuclease activity simply by inducing a conformational change in Pso2. However, this could be a component of the mechanism, especially when considering the autoinhibitory nature of the Pso2 NTD. Hrq1 could interact with the Pso2 N-terminus such that it conformationally prohibits the Pso2 NTD from inhibiting nuclease activity. While our data indicate that this is not the sole explanation for Hrq1-mediated stimulation of Pso2 nuclease activity, we cannot exclude this proposed phenomenon as a possible component of the mechanism of stimulation.
Pso2 is reported to have an endonucleolytic activity under certain in vitro conditions (18) 5C ) but both stimulate Pso2 nuclease activity on the same substrate ( Fig. 5A and B ) argue against this. Why then the need for catalytic activity by Hrq1? According to the model in the field ((15) and Fig. 7 ), Pso2 acts after the NER machinery makes incisions on one strand of DNA on either side of the ICL. In vitro, Pso2 can load at a nick to degrade DNA in the 5′ → 3′ direction (18) , so Pso2 likely does not require its endonuclease activity during ICL repair, when it presumably loads at the 5′ nick in the DNA upstream of the ICL. That said, we have not tested the possible stimulation of Pso2 endonuclease activity by Hrq1 in vitro. It is also unknown if Hrq1 can load at a nick to initiate DNA unwinding. Such experiments are ongoing because specifically identifying how Hrq1 stimulates Pso2 nuclease activity will be important when translating this model to human RECQL4 and SNM1A.
Regulation of Pso2 nuclease activity
Why does Pso2 need to be stimulated by Hrq1 for appropriate ICL resistance? Pso2 expression is extremely low, and ICL damage results in only a mild ~4-fold induction of Pso2 ((48), unpublished observations). The overexpression of Pso2 in yeast is extremely toxic (Fig. S5 ), and the Pso2 N-terminus autoinhibits nuclease activity (Fig. 6B ), providing another regulatory mechanism to prevent rampant Pso2 digestion. Thus, Pso2 expression is in a delicate balance between being sufficient for ICL repair and nucleotoxic. Coupling Hrq1 to Pso2 in ICL repair may allow for modulated, site-specific nuclease activity. In this scenario, Hrq1 and Pso2 are recruited to ICLs via a currently unknown mechanism, and low levels of Pso2 are sufficient for ICL degradation, as Hrq1 is present to stimulate translesion exonuclease activity (Fig. 7) . This scheme allows for cells to maintain a low Pso2 concentration but still have the appropriate amount of nuclease activity at the lesion. In the absence of Hrq1, Pso2 is still recruited to ICLs and can aid in their repair, but the process is less efficient, accounting for the mild ICL sensitivity of hrq1Δ cells ( Fig. 1 and S1 ). Finally, in the absence of Pso2 itself, other pathways can repair some amount of the lesions (e.g., the S. cerevisiae proto-FA pathway (15) ), but many ICLs likely persist, resulting in mutagenesis and cell death (Fig. 7) .
These data provide evidence for a novel role in ICL repair for RecQ4 helicases and further support the model that translesion nuclease activity by Pso2 is an important step in ICL repair. Because components of this mechanism are likely conserved in all domains of life, future work will be required to identify new proteins that facilitate RecQ4-medicated ICL repair and determine how RecQ4 helicases operate across evolution. How cells utilize such a diverse set of tools for ICL repair is likely determined by the molecular context in which the lesions are encountered, and pathway choice is an important but largely unexplored element of ICL repair.
Experimental procedures
Reagents, nucleotides, and oligonucleotides γ[ 32 P]-ATP and α[ 32 P]-dCTP were purchased from PerkinElmer (Waltham, MA). Unlabelled ATP was purchased from DOT Scientific (Burton, MI), and all oligonucleotides were synthesized by IDT (Coralville, IA) and are listed in Supplemental Table 1 .
DNA inter-strand crosslinker sensitivity analysis
The sensitivity of S. cerevisiae mutants (Table  S2 ) to DNA damaging agents was analysed as described (14) . Briefly, cells were grown overnight in 1% yeast extract, 2% peptone, and 2% dextrose (YPD) medium with aeration and diluted to an optical density at 660 nm (OD660) of 1 in sterile water. Cells were then serially diluted 10-fold to 10 -4 , and 5 µL of each dilution was spotted onto YPD plates lacking or containing the indicated drug. For MMC and DEB, plates contained 50 μg/mL of the respective drug, unless otherwise indicated. Plates containing 20 µg/mL 8-MOP were treated with 365 nm UVA (Sylvania fluorescent lamp) in a dark box for 30 min after cells were spotted to activate the ICL reaction. MMS was used at 0.03%. All plates were incubated in the dark for 2 days at 30°C and imaged on a flat-bed scanner. The strains were constructed in the wild type YPH499 background (MATa, ura3-52, lys2-801_amber, ade2-101_ochre, trp1Δ63, his3Δ200, leu2Δ1) (49) using standard methods.
Protein expression and purification
The S. cerevisiae Pso2 expression vector harbouring a C-terminal 6xHis-tag was kindly provided by Murray Junop (Schulich School of Medicine and Dentistry, Western University) (18) . Pso2-6xHis was expressed in Rosetta 2(DE3) pLysS (Novagen) cells by growing cultures to an OD600 of 0.6 at 37°C followed by induction with 1 mM isopropyl β-D-1thiogalactopyranoside for 4 h at 30°C. Cells were harvested by centrifugation at 5000 rpm for 10 min at 4°C, and the cell pellet was frozen at -80°C. The frozen cell mass was thawed in Resuspension Buffer (50 mM NaHEPES, pH 7, 50 mM NaCl, 5% glycerol, and 2 mM DTT) supplemented with fresh protease inhibitor mix and 20 μg/mL DNase I. Lysis was performed using several passes through a cell cracker, and the lysate was clarified by centrifugation at 14,000 rpm for 30 min at 4°C. Clarified lysate was loaded onto a gravity column containing 1 mL HIS-Select Nickel Affinity Gel (Sigma) preequilibrated with Resuspension Buffer. The column was washed with 5 column volumes (CVs) of Resuspension Buffer and 5 CVs of Resuspension Buffer supplemented with 5 mM ATP. Pso2 was eluted with Resuspension Buffer supplemented with 100 mM imidazole, and the Pso2-containing fractions were pooled. The eluate was then loaded onto 1 mL HiTrap Heparin HP column (GE Healthcare) and washed with 10 CVs Heparin Buffer (50 mM NaHEPES, pH 7, 50 mM NaCl, 5% glycerol, and 2 mM DTT). Pso2 was eluted via a 20-CV linear salt gradient with Heparin Buffer from 50 mM to 1 M NaCl. Pooled Pso2 fractions were concentrated and buffer exchanged into storage buffer (25 mM NaHEPES, pH 7.6, 30% glycerol, 300 mM NaOAc pH 7.6, 25 mM NaCl, 5 mM MgOAc, 1 mM DTT, and 0.01% Tween-20). Pso2ΔN and the catalytically inactive Pso2-H611A and Pso2ΔN-H611A mutants were purified identically to wild-type.
Expression and purification of Hrq1 and RECQL4 were described previously (14) . Sgs1 was a generous gift from Hengyao Niu (Indiana University) and Petr Cejka (Università della Svizzera italiana).
Hrq1ΔN was purified similarly to the wildtype Hrq1 used in (25) . Briefly, a plasmid harboring the 3xStrep-Hrq1ΔN-6xHis construct was transformed into Rosetta 2(DE3) pLysS cells and expressed overnight in autoinduction media (50) . Cells were lysed in Hrq1ΔN Resuspension Buffer (50 mM NaHEPES,pH 8, 5% glycerol, 150 mM NaOAc, pH8, 5 mM MgOAc, and 0.05% Tween-20) as in the Pso2 purification, and clarified lysate was loaded onto a 1 mL StrepTrap column. The column was washed with 20 CVs Hrq1ΔN Resuspension Buffer supplemented with 600 mM NaOAc, followed by a wash with Hrq1ΔN Resuspension Buffer supplemented with 5 mM ATP. Protein was eluted in buffer containing 2.5 mM desthiobiotin. Protein-containing fractions were pooled and loaded onto a 0.5-mL His60 column. The column was washed with 10 CVs Hrq1ΔN Resuspension Buffer containing 10 mM imidazole, followed by a 1-CV wash each with buffer supplemented with 50 and 100 mM imidazole. Protein was eluted in Hrq1ΔN Resuspension Buffer supplemented with 500 mM imidazole and stored as for Pso2. Mycobacterium smegmatis SftH was purified identically.
Further details concerning the construction of expression vectors and protein purification are available upon request. Mass spectrometry analysis of all protein preparations demonstrated that they were not contaminated by E. coli helicases or nucleases.
Preparation of DNA substrates
The uncrosslinked double-stranded (ds)DNA substrate was prepared by annealing equimolar amounts of MB1614 to MB1461 in Annealing Buffer (20 mM Tris-HCl, pH 8, 4% glycerol, 0.1 mM EDTA, 40 µg/mL BSA, 10 mM DTT, and 10 mM MgOAc) overnight at 37°C (51) ( Table S1 ). Because Pso2 nuclease activity is greatly stimulated by a 5′-phosphate, only the digested strand (MB1614) was phosphorylated by IDT. The substrate was designed such that the digested strand is 6 nt shorter than the undigested strand to allow 3′ fill-in by Klenow Fragment (3′-5′ exo-; NEB) with α[ 32 P]-dCTP and cold dATP, dTTP, and dGTP for 30 min at 37°C. After labelling, cold dCTP was also added for another 30 min at 37°C to facilitate complete fill-in to yield a 30-bp blunt dsDNA. The nuclease substrate was separated from unincorporated dNTPs using an illustra ProbeQuant G-50 micro column (GE Healthcare) according to the manufacturer's instructions.
The ICL-containing substrate was prepared using spontaneous crosslink formation from an abasic site as previously reported (33) . Oligonucleotides MB1599 and MB1600 were annealed by heating to 95°C for 5 min followed by slow cooling to room temperature overnight. The digested strand (MB1599) was 5′ phosphorylated as above and contained a deoxyuracil (dU) 7-nt from the 5′ end. The substrate was then treated with 50 U of uracil DNA glycosylase (NEB) for 2 h at 37°C to form the abasic site. The DNA was phenol/chloroform extracted and precipitated with 10% 3 M NaOAc, pH 5.2, and five volumes of 100% ethanol. Precipitated DNA was stored at -20°C for 1 h and pelleted at 15,000 rpm for 30 min at 4°C. The supernatant was removed, and the pellet was washed twice with cold 80% ethanol. After the last wash was completely removed, the DNA was resuspended in 50 mM NaHEPES, pH 7, and 100 mM NaCl and stored in the dark for 5 days with gentle agitation to form the ICL. Once the crosslink was formed, the substrate was labelled with α[ 32 P]-dCTP as above. The DNA was heated at 95°C for 10 min to denature any uncrosslinked substrate, and the entire sample was loaded onto a 20% 19:1 acrylamide:bis-acrylamide 6 M urea denaturing gel and run in 1x TBE buffer (90 mM Tris-HCl pH 8.0, 90 mM boric acid, and 2 mM EDTA, pH 8.0) at 10 V/cm. The gel was exposed to classic blue autoradiography film to identify the slower migrating ICLcontaining dsDNA, which was gel extracted into 0.5x TBE buffer overnight and precipitated as above. The crosslinked substrate was finally resuspended in H2O.
To make forked DNA for helicase assays, the top strand (MB733) was 5′ labelled with [ 32 P]-ATP and T4 polynucleotide kinase (T4 PNK; NEB) for 1 h at 37°C and cleaned up with a G-50 micro column as above. Equimolar cold bottom strand (MB734) was incubated with labelled top strand overnight at 37°C in Annealing Buffer. Helicase assays using blunt dsDNA were performed with the undamaged nuclease assay substrate described above (MB1614 annealed to MB1461).
Gel-based nuclease assays
Nuclease assays were performed for 30 min at 30°C with the indicated protein concentration in Nuclease Buffer (20 mM Tris-acetate, pH 7.6, 50 mM NaOAc, pH 7.6, 7.5 mM MgOAc, and 0.01% Tween-20) with 1 nM labelled DNA substrate. For nuclease assays involving helicases, 5 mM ATP was also included unless stated otherwise. Reactions were stopped with the addition of Loading Dye (95% formamide and 0.02% bromophenol blue) and by heating at 95°C for 5 min. Reactions were loaded onto 20% 19:1 acrylamide:bis-acrylamide 6 M urea denaturing gels in 1x TBE buffer and run at 2400 V for 90 min. Gels were dried under vacuum, imaged using a Typhoon FLA 9500, and quantified using ImageQuant 5.2.
smFRET nuclease assays
Single molecule assays were performed by using a home-built prism type total internal reflection fluorescence (TIRF) microscope at room temperature (24 ± 1°C). The microscope setup, slide preparation, and DNA immobilization were performed as described (34) . The experimental protocol and flow setup were slightly modified from a previously published method (52) . The MB1621 DNA oligonucleotide was purchased from IDT with 5'-Cy3, 3'-biotin, and an internal amine modification (Supplementary Table 1 ). The amine modification was used for Cy5 labeling as described (53) . The labelled oligonucleotide was annealed to MB1620 or MB1622 to make the ICL-containing or undamaged substrate, respectively. The abasic site crosslink was formed as above.
The buffer used for Pso2 nuclease activity measurement was prepared freshly by mixing an oxygen scavenging system (1 mg/mL glucose oxidase, 0.8% v/v glucose, ~10 mM Trolox, and 0.03 mg/mL catalase) before taking each single molecule image. A solidstate 532 nm laser was used for FRET measurement. Images were recorded with a time resolution of 100 ms and analysed by Matlab. FRET efficiency (E) was calculated by the equation: Mutation of HRQ1 is epistatic to pso2 for MMC sensitivity. Saturated overnight cultures of strains with the genotypes indicated on the left were diluted to OD660 = 1.0 and then further serially diluted 10-fold to 10 -4 . Equal volumes of each dilution were then spotted onto rich medium containing the solvent control (DMSO) or rich medium supplemented with the indicated concentration of MMC. B. Mutation of HRQ1 is epistatic to pso2 for DEB sensitivity. The assay was performed as described above, and the DMSO control plate is shown again for ease of comparison. Mutation of SGS1 is not epistatic with either hrq1 or pso2 in these assays. These results are representative of ≥ 3 independent experiments. Model of ICL repair in WT, hrq1, and pso2 cells. In the first step of ICL repair, the NER machinery cuts one strand of DNA on either side of the ICL. Then, in WT cells, Hrq1 and Pso2 are recruited to the lesion to digest away the incised strand, leaving an adducted base. Translesion synthesis (TLS) polymerases fill the gap, and NER removes the adducted base. In hrq1 cells, Pso2 is still recruited to the ICL, but its poor translesion nuclease activity in the absence of Hrq1 yields some amount of incompletely processed substrates, which can lead to mutagenesis or cell death. In cells lacking Pso2, other nucleases (e.g., Exo1) may be recruited to ICLs, but there less optimal activity on such substrates can also lead to mutagenesis or cell death.
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Pso2 overexpression in Saccharomyces cerevisiae
Pso2 was cloned under the control of the galactose-inducible promoter in pESC-URA and transformed into cells deleted for pso2. Empty vector strains were also constructed. Overnight cultures were grown in uracil dropout medium supplemented with 2% raffinose. Cells were pelleted and washed with sterile H2O before being added to a 96-well plate at an OD660 of 0.01 in uracil dropout medium supplemented with either 2% glucose or galactose. Cells were incubated at 30°C with vigorous shaking in a plate reader for 48 h, and OD660 readings were taken every 15 min. The resulting growth curves were used to calculate the mean OD660 for each condition. The mean values were taken from ≥ 3 independent experiments and averaged. The reported mean OD660 values were determined by dividing Pso2 overexpression strains by the mean OD660 of the empty vector strains in either glucose (repressed expression) or galactose (overexpression) as indicated.
Helicase assays
Helicase assays were performed as reported (14) . Briefly, 2 nM labelled DNA substrate was incubated with the indicated helicase concentration in Nuclease Buffer with 5 mM ATP for 30 min at 30°C. For RECQL4 helicase assays, 15 nM cold ssDNA trap was added to capture the unwound product. The trap was added last along with ATP to start the reaction. Assays were stopped with 1x Stop-Load dye (5% glycerol, 20 mM EDTA, 0.05% SDS, and 0.25% bromophenol blue) and loaded onto 12% 19:1 acrylamide:bis-acrylamide nondenaturing gels and run in 1x TBE at 10 V/cm. Gels were dried under vacuum, imaged using a Typhoon FLA 9500, and quantified using ImageQuant 5.2. Figure S1 . Mutation of HRQ1 and PSO2 sensitizes cells to ICL damage. A. Saturated overnight cultures of strains with the genotypes indicated on the left were diluted to OD660 = 1.0 and then further serially diluted 10-fold to 10 -4 . Equal volumes of each dilution were then spotted onto rich medium (YPD) or rich medium supplemented with MMC, 8-MOP, DEB, or MMS. The plates containing 8-MOP were also exposed to UVA to activate the 8-MOP for crosslinking. The effect of the DNA damaging agent is diagrammed below each plate: MMC does not deform the DNA backbone, 8-MOP + UVA results in ~25° of local unwinding of the DNA around the lesion, DEB kinks the DNA backbone, and MMS alkylates the DNA. B. 8-MOP + UVA sensitivity of hrq1, pso2, and sgs1 mutants. The assay was performed as described in Figure 1A , and the DMSO control plate from Figure 1 is shown again for ease of comparison. These results are representative of ≥ 3 independent experiments. Figure S2 . Representative gel images of Hrq1-mediated Pso2 stimulation. A. Schematic of gel-based nuclease assay. The digested strand is 5′ phosphorylated and labelled on the 3′ end via Klenow fill-in (red nucleotides). Pso2 digestion is measured by the smaller bands as observed on denaturing gels. B. Nuclease activity of Pso2 or nuclease-inactive Pso2-H611A in the presence or absence of Hrq1 or helicase-inactive Hrq1-K318A. The indicated combination of enzymes (50 nM nuclease and 150 nM helicase) were incubated with dsDNA for 30 min. Lanes 1-6 were run on the same gel, whereas lanes 7-10 were identical conditions run on a separate gel (with intervening lanes removed for simplicity). Quantification of similar data from at least three independent experiments is reported in Figure 2C . Figure S3 . Control smFRET nuclease assays. A. smFRET analysis on dsDNA under various conditions. The data used to plot the ssDNA and dsDNA histograms were collected in the absence of protein to determine the FRET values of digested and undigested substrate, respectively. Hrq1 +/-ATP had no effect on the substrate, as expected by previous experiments demonstrating a lack of Hrq1 helicase activity on similar blunt dsDNA substrates (14) . Pso2 requires the presence of Mg 2+ for nuclease activity. B. The same control experiments from A) were performed with XL-DNA. Figure S6 . The Pso2 N-terminus is an autoinhibitory domain. A. A DISOPRED profile for Pso2, as analysed by the UCL Department of Computer Science web server (http://bioinf.cs.ucl.ac.uk/psipred/?disopred=1) indicates that the N-terminal domain of Pso2 (aa 1~210) is predicted to be natively disordered. B. Hrq1 is unable to maximally stimulate Pso2ΔN. Pso2ΔN (50 nM) nearly completely digested the dsDNA substrate in Figure 6B , but here, 2 nM Pso2ΔN has comparable nuclease activity to 50 nM full-length Pso2. The addition of Hrq1 yielded very mild stimulation of Pso2ΔN nuclease activity at this concentration, suggesting that the Nterminus of Pso2 is required for Hrq1-mediated stimulation. 
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